Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1987 Feb;57(2):176-80.
doi: 10.1136/hrt.57.2.176.

Cardiac damage in polymyositis associated with antibodies to tissue ribonucleoproteins

Cardiac damage in polymyositis associated with antibodies to tissue ribonucleoproteins

W M Behan et al. Br Heart J. 1987 Feb.

Abstract

Cardiac damage, consisting of mild diffuse myocarditis or severe inflammation and fibrosis of the conduction system or both, occurs in more than 70% of patients with idiopathic polymyositis. The lesions are strikingly similar to those detected in the infants of mothers with connective tissue diseases. In these infants the damage is associated with the transplacental passage of a maternal antibody to tissue ribonucleoproteins (anti-Ro). The same antibody was identified in 60% of 55 patients with polymyositis and in 69% (23/33) of those with associated cardiac damage including four with complete heart block. Forty five per cent of those patients who were anti-Ro seropositive had no clinical or electrocardiographic evidence of cardiac lesions. They were in the acute phase of illness, however, and no other more detailed heart investigations had been done. It is postulated that cardiac damage in polymyositis is caused by the antibody and that its presence may serve as a marker for heart involvement.

PubMed Disclaimer

References

    1. Arch Pathol. 1974 Jan;97(1):51-7 - PubMed
    1. N Engl J Med. 1983 Jul 28;309(4):209-12 - PubMed
    1. Ann N Y Acad Sci. 1975 Jun 30;254:505-15 - PubMed
    1. N Engl J Med. 1983 Jul 28;309(4):236-8 - PubMed
    1. Clin Exp Immunol. 1983 Dec;54(3):731-8 - PubMed

Publication types